Patients SURF303 Clinical Trial We are working to advance SURF303, our clinical study of dabogratinib for LG-UTUC. Please complete this form to receive updates. "*" indicates required fields First Name*Last Name*Email Address* Phone*What best describes you? (select one)*What best describes you? (select one) *I am a primary caregiver of a person with LG-UTUCI am a person with LG-UTUCI am a healthcare professionalI am a member of an advocacy related to LG-UTUCNone of the above applyI would like to learn more about the SURF303 Clinical Trial* Yes No
